Sally Beauty Holdings, Inc. (SBH) stock
Close on Nov 17, 2026Market cap $1.72BP/E 9.6Yield –
Earnings
Sally Beauty's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Quarterly results
Revenue and earnings per share from each of Sally Beauty's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Adj. EPS | Source |
|---|---|---|---|---|---|---|
| Q1 FY2027ended Dec 31, 2026 | Feb 8, 2027Expected | – | – | – | – | – |
| Q4 FY2026ended Sep 30, 2026 | Nov 10, 2026before the open | $953.00M | +0.6% | $0.60 | $0.62 | Release |
| Q3 FY2026ended Jun 30, 2026 | Aug 3, 2026before the open | $935.00M | +0.2% | $0.55 | $0.55 | Release |
| Q2 FY2026ended Mar 31, 2026 | May 11, 2026before the open | $903.00M | +2.3% | $0.43 | $0.44 | Release |
| Q1 FY2026ended Dec 31, 2025 | Feb 9, 2026before the open | $943.00M | +0.5% | $0.45 | $0.48 | Release |
| Q4 FY2025ended Sep 30, 2025 | Nov 13, 2025before the open | $947.00M | +1.3% | $0.49 | $0.55 | Release |
| Q3 FY2025ended Jun 30, 2025 | Aug 5, 2025before the open | $933.30M | -1.0% | $0.44 | $0.51 | Release |
| Q2 FY2025ended Mar 31, 2025 | May 12, 2025before the open | $883.00M | -2.8% | $0.38 | $0.42 | Release |
| Q1 FY2025ended Dec 31, 2024 | Feb 13, 2025before the open | $938.00M | +0.7% | $0.58 | $0.43 | Release |
| Q4 FY2024ended Sep 30, 2024 | Nov 14, 2024before the open | $935.00M | +1.5% | $0.46 | $0.50 | Release |
| Q3 FY2024ended Jun 30, 2024 | Aug 8, 2024before the open | $942.30M | +1.2% | $0.36 | $0.45 | Release |
| Q2 FY2024ended Mar 31, 2024 | May 9, 2024before the open | $908.40M | -1.1% | $0.27 | $0.35 | Release |
| Q1 FY2024ended Dec 31, 2023 | Feb 1, 2024before the open | $931.30M | -2.7% | $0.35 | $0.39 | Release |
| Q4 FY2023ended Sep 30, 2023 | Nov 14, 2023before the open | $921.40M | -4.3% | $0.39 | $0.42 | Release |
| Q3 FY2023ended Jun 30, 2023 | Aug 3, 2023before the open | $931.00M | -3.2% | $0.46 | $0.49 | Release |
| Q2 FY2023ended Mar 31, 2023 | May 4, 2023before the open | $918.70M | +0.8% | $0.37 | $0.41 | Release |
| Q1 FY2023ended Dec 31, 2022 | Feb 2, 2023before the open | $957.10M | -2.4% | $0.46 | $0.52 | Release |
| Q4 FY2022ended Sep 30, 2022 | Nov 10, 2022before the open | $962.50M | -2.8% | $0.20 | $0.50 | Release |
| Q3 FY2022ended Jun 30, 2022 | Aug 4, 2022before the open | $961.50M | – | $0.43 | $0.55 | Release |
| Q2 FY2022ended Mar 31, 2022 | May 5, 2022before the open | $911.40M | – | $0.42 | $0.47 | Release |
| Q1 FY2022ended Dec 31, 2021 | Feb 2, 2022before the open | $980.30M | – | $0.60 | $0.63 | Release |
| Q4 FY2021ended Sep 30, 2021 | Nov 12, 2021before the open | $990.30M | – | $0.59 | $0.64 | Release |
| Q3 FY2021ended Jun 30, 2021 | Jul 29, 2021before the open | – | – | – | – | Filing |
| Q2 FY2021ended Mar 31, 2021 | May 6, 2021before the open | – | – | – | – | Filing |
| Q1 FY2021ended Dec 31, 2020 | Feb 4, 2021before the open | – | – | – | – | Filing |
| Q4 FY2020ended Sep 30, 2020 | Nov 12, 2020before the open | – | – | – | – | Filing |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Current guidance
Sally Beauty's latest outlook for periods it has not reported yet, compared with what it said before
| Metric | Period | Guidance | Before | Change | Given |
|---|---|---|---|---|---|
| Consolidated Net Sales | Q1 FY2027 | $945.00M – $955.00M | – | New | Nov 10, 2026 |
| Comparable Sales Growth | Q1 FY2027 | +0.5% – +1.5% | – | New | Nov 10, 2026 |
| Adjusted Operating Earningsnon-GAAP | Q1 FY2027 | $75.00M – $80.00M | – | New | Nov 10, 2026 |
| Adjusted Diluted EPSnon-GAAP | Q1 FY2027 | $0.48 – $0.52 | – | New | Nov 10, 2026 |
| Consolidated Net Sales | FY2027 | $3.77B – $3.81B | – | New | Nov 10, 2026 |
| Comparable Sales Growth | FY2027 | +1% – +2% | – | New | Nov 10, 2026 |
| Adjusted Operating Earningsnon-GAAP | FY2027 | $334.00M – $347.00M | – | New | Nov 10, 2026 |
| Adjusted Diluted EPSnon-GAAP | FY2027 | $2.20 – $2.30 | – | New | Nov 10, 2026 |
| Free Cash Flownon-GAAP | FY2027 | $200.00M | – | New | Nov 10, 2026 |
| Capital Expenditures | FY2027 | $140.00M | – | New | Nov 10, 2026 |
| Consolidated net sales growth | FY2028 | +1% – +3% | – | New | Nov 13, 2025 |
| Adjusted Operating Earnings growthnon-GAAP | FY2028 | +3% – +5% | – | New | Nov 13, 2025 |
| Adjusted Diluted EPS growthnon-GAAP | FY2028 | +10% | – | New | Nov 13, 2025 |
| Free Cash Flownon-GAAP | FY2028 | $200.00M | – | New | Nov 13, 2025 |
| Capital expenditures | FY2028 | $90.00M – $120.00M | – | New | Nov 13, 2025 |
Guidance vs results
The last range Sally Beauty gave before each report, against the figure it then reported. Full years add up the four quarters.
| Period | Metric | Guidance | Actual | Result |
|---|---|---|---|---|
| FY2026 | Adjusted Diluted EPS | $2.04 – $2.08 | $2.09Σ4Q | Above range |
| FY2026 | Revenue | $3.73B – $3.73B | $3.73BΣ4Q | Within range |
| Q3 FY2026 | Adjusted Diluted EPS | $0.52 – $0.56 | $0.55 | Within range |
| Q3 FY2026 | Revenue | $932.00M – $942.00M | $935.00M | Within range |
| Q2 FY2026 | Adjusted Diluted EPS | $0.39 – $0.42 | $0.44 | Above range |
| Q2 FY2026 | Revenue | $895.00M – $905.00M | $903.00M | Within range |
| Q1 FY2026 | Adjusted Diluted EPS | $0.43 – $0.47 | $0.48 | Above range |
| Q1 FY2026 | Revenue | $935.00M – $945.00M | $943.00M | Within range |
Guidance history
Every forecast Sally Beauty put in an earnings release, newest first
| Given | Metric | Period | Guidance | Change |
|---|---|---|---|---|
| Nov 10, 2026 | Capital Expenditures | FY2027 | $140.00M | New |
| Nov 10, 2026 | Comparable Sales Growth | Q1 FY2027 | +0.5% – +1.5% | New |
| Nov 10, 2026 | Comparable Sales Growth | FY2027 | +1% – +2% | New |
| Nov 10, 2026 | Adjusted Diluted EPS | Q1 FY2027 | $0.48 – $0.52 | New |
| Nov 10, 2026 | Adjusted Diluted EPS | FY2027 | $2.20 – $2.30 | New |
| Nov 10, 2026 | Free Cash Flow | FY2027 | $200.00M | New |
| Nov 10, 2026 | Adjusted Operating Earnings | Q1 FY2027 | $75.00M – $80.00M | New |
| Nov 10, 2026 | Adjusted Operating Earnings | FY2027 | $334.00M – $347.00M | New |
| Nov 10, 2026 | Consolidated Net Sales | Q1 FY2027 | $945.00M – $955.00M | New |
| Nov 10, 2026 | Consolidated Net Sales | FY2027 | $3.77B – $3.81B | New |
| Aug 3, 2026 | Capital Expenditures | FY2026 | $100.00M | Reaffirmed |
| Aug 3, 2026 | Comparable Sales | FY2026 | +0.5% | New |
| Aug 3, 2026 | Adjusted Diluted EPS | FY2026 | $2.04 – $2.08 | Narrowed |
| Aug 3, 2026 | Free Cash Flow | FY2026 | $200.00M | Reaffirmed |
| Aug 3, 2026 | Adjusted Operating Earnings | FY2026 | $329.00M – $335.00M | Narrowed |
| Aug 3, 2026 | Consolidated Net Sales | FY2026 | $3.73B – $3.73B | Lowered |
| May 11, 2026 | Capital Expenditures | FY2026 | $100.00M | Reaffirmed |
| May 11, 2026 | Adjusted Diluted EPS | FY2026 | $2.02 – $2.10 | Reaffirmed |
| May 11, 2026 | Adjusted Diluted EPS | Q3 FY2026 | $0.52 – $0.56 | New |
| May 11, 2026 | Free Cash Flow | FY2026 | $200.00M | Reaffirmed |
| May 11, 2026 | Adjusted Operating Earnings | FY2026 | $328.00M – $342.00M | Reaffirmed |
| May 11, 2026 | Adjusted Operating Earnings | Q3 FY2026 | $83.00M – $89.00M | New |
| May 11, 2026 | Consolidated Net Sales | FY2026 | $3.73B – $3.75B | Narrowed |
| May 11, 2026 | Consolidated Net Sales | Q3 FY2026 | $932.00M – $942.00M | New |
| Feb 9, 2026 | Capital Expenditures | FY2026 | $100.00M | Reaffirmed |
| Feb 9, 2026 | Comparable Sales | Q2 FY2026 | +0.5% – +1.5% | New |
| Feb 9, 2026 | Adjusted Diluted EPS | FY2026 | $2.02 – $2.10 | Raised |
| Feb 9, 2026 | Adjusted Diluted EPS | Q2 FY2026 | $0.39 – $0.42 | New |
| Feb 9, 2026 | Free Cash Flow | FY2026 | $200.00M | Reaffirmed |
| Feb 9, 2026 | Adjusted Operating Earnings | FY2026 | $328.00M – $342.00M | Reaffirmed |
| Feb 9, 2026 | Adjusted Operating Earnings | Q2 FY2026 | $68.00M – $71.00M | New |
| Feb 9, 2026 | Consolidated Net Sales | FY2026 | $3.71B – $3.77B | Reaffirmed |
| Feb 9, 2026 | Consolidated Net Sales | Q2 FY2026 | $895.00M – $905.00M | New |
| Nov 13, 2025 | Capital Expenditures | FY2026 | $100.00M | New |
| Nov 13, 2025 | Capital expenditures | FY2028 | $90.00M – $120.00M | New |
| Nov 13, 2025 | Adjusted Diluted EPS | FY2026 | $2.00 – $2.10 | New |
| Nov 13, 2025 | Adjusted Diluted EPS | Q1 FY2026 | $0.43 – $0.47 | New |
| Nov 13, 2025 | Adjusted Diluted EPS growth | FY2028 | +10% | New |
| Nov 13, 2025 | Free Cash Flow | FY2026 | $200.00M | New |
| Nov 13, 2025 | Free Cash Flow | FY2028 | $200.00M | New |
| Nov 13, 2025 | Adjusted Operating Earnings | FY2026 | $328.00M – $342.00M | New |
| Nov 13, 2025 | Adjusted Operating Earnings | Q1 FY2026 | $75.00M – $80.00M | New |
| Nov 13, 2025 | Adjusted Operating Earnings growth | FY2028 | +3% – +5% | New |
| Nov 13, 2025 | Consolidated Net Sales | FY2026 | $3.71B – $3.77B | New |
| Nov 13, 2025 | Consolidated Net Sales | Q1 FY2026 | $935.00M – $945.00M | New |
| Nov 13, 2025 | Consolidated net sales growth | FY2028 | +1% – +3% | New |
| Aug 5, 2025 | Adjusted Operating Margin | FY2025 | 8.6% – 8.7% | New |
| May 12, 2025 | Adjusted Operating Margin | Q3 FY2025 | 8% – 8.5% | New |
| May 12, 2025 | Adjusted Operating Margin | FY2025 | 8% – 8.5% | Lowered |
| Feb 13, 2025 | Adjusted Operating Margin | Q2 FY2025 | 8% – 8.3% | New |
| Feb 13, 2025 | Adjusted Operating Margin | FY2025 | 8.5% – 9% | Reaffirmed |
| Nov 14, 2024 | Adjusted Operating Margin | Q1 FY2025 | 8% – 8.4% | New |
| Nov 14, 2024 | Adjusted Operating Margin | FY2025 | 8.5% – 9% | New |
| Aug 8, 2024 | Capital expenditures | FY2024 | $100.00M | Reaffirmed |
| Aug 8, 2024 | Gross Margin | FY2024 | 50.5% – 51% | Reaffirmed |
| Aug 8, 2024 | Adjusted Operating Margin | FY2024 | 8.5% | Reaffirmed |
| Aug 8, 2024 | Operating Cash Flow | FY2024 | $240.00M | Reaffirmed |
| May 9, 2024 | Capital expenditures | FY2024 | $100.00M | Reaffirmed |
| May 9, 2024 | Gross Margin | FY2024 | 50.5% – 51% | Raised |
| May 9, 2024 | Adjusted Operating Margin | FY2024 | 8.5% | Lowered |
| May 9, 2024 | Operating Cash Flow | FY2024 | $240.00M | Lowered |
| Feb 1, 2024 | Capital expenditures | FY2024 | $100.00M | Reaffirmed |
| Feb 1, 2024 | Gross Margin | FY2024 | 50% | Reaffirmed |
| Feb 1, 2024 | Adjusted Operating Margin | FY2024 | 9% | Reaffirmed |
| Feb 1, 2024 | Operating Cash Flow | FY2024 | $260.00M | Reaffirmed |
| Nov 14, 2023 | Capital expenditures | FY2024 | $100.00M | New |
| Nov 14, 2023 | Gross Margin | FY2024 | 50% | New |
| Nov 14, 2023 | Adjusted Operating Margin | FY2024 | 9% | New |
| Nov 14, 2023 | Operating Cash Flow | FY2024 | $260.00M | New |
| Aug 3, 2023 | Gross margin | FY2023 | 50% | Reaffirmed |
| Aug 3, 2023 | Adjusted Operating Margin | FY2023 | 9% – 9.4% | Narrowed |
| May 4, 2023 | Gross margin | FY2023 | 50% | Reaffirmed |
| May 4, 2023 | Adjusted Operating Margin | FY2023 | 8.5% – 9.5% | Reaffirmed |
| Feb 2, 2023 | Gross margin | FY2023 | 50% | Reaffirmed |
| Feb 2, 2023 | Adjusted Operating Margin | FY2023 | 8.5% – 9.5% | Reaffirmed |
| Nov 10, 2022 | Gross Margin | FY2023 | 50% | New |
| Nov 10, 2022 | Adjusted Operating Margin | FY2023 | 8.5% – 9.5% | New |
| Aug 4, 2022 | GAAP gross margin | FY2022 | 70 | New |
| Aug 4, 2022 | Adjusted Gross Margin | FY2022 | 50 | New |
| Aug 4, 2022 | GAAP operating margin | FY2022 | 10.3% | Lowered |
| Aug 4, 2022 | Adjusted Operating Margin | FY2022 | 10.5% | Lowered |
| Aug 4, 2022 | Net store count | FY2022 | -90 | New |
| Aug 4, 2022 | Net sales | FY2022 | -2% | Lowered |
| May 5, 2022 | Gross margin | FY2022 | 40 – 60 | Reaffirmed |
| May 5, 2022 | GAAP operating margin | FY2022 | 11% | New |
| May 5, 2022 | Adjusted Operating Margin | FY2022 | 11% | New |
| May 5, 2022 | Net store count | FY2022 | -2% – -1% | Lowered |
| Feb 2, 2022 | Gross margin | FY2022 | 40 – 60 | Reaffirmed |
| Feb 2, 2022 | GAAP operating margin | FY2022 | 90 – 110 | Reaffirmed |
| Feb 2, 2022 | Net store count | FY2022 | +1% – +2% | Reaffirmed |
| Feb 2, 2022 | Net sales | FY2022 | +3% – +4% | Reaffirmed |
| Nov 12, 2021 | Gross margin | FY2022 | 40 – 60 | New |
| Nov 12, 2021 | GAAP operating margin | FY2022 | 90 – 110 | New |
| Nov 12, 2021 | Net store count | FY2022 | +1% – +2% | New |
| Nov 12, 2021 | Net sales | FY2022 | +3% – +4% | New |
Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.
Press releases
Releases Sally Beauty filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Results
See a number that looks wrong?